Kim Sablich - Insider Trading & Ownership

Entity
Individual
Location
C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, Brisbane, CA
Summary
The estimated net worth of Kim Sablich is at least $3.39M dollars as of June 7, 2023. Kim Sablich is the EVP, GM of U.S. of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $3.39M. Kim Sablich is the Director of Eiger BioPharmaceuticals, Inc. and owns shares of Eiger BioPharmaceuticals, Inc. (EIGRQ) stock worth about $1.79K.
All Insider Reports
All Insider Reports

Ownership of Kim Sablich

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
JAZZ Jazz Pharmaceuticals plc EVP, GM of U.S. $3.39M Jun 5, 2023
EIGRQ Eiger BioPharmaceuticals, Inc. Director $1.79K Mar 1, 2023

Insider Transactions Reported by Kim Sablich:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.